The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma
Philipp Berning(University Hospital Münster), Jenny Potratz(University Hospital Münster)
Cited by 4
Related Papers
The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling
|Cell Communication and Signaling|2018|29